Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders
Ross Baker, Professor at The University of Notre Dame Australia, Founding Chair of Perth Blood Institute, Professor and Director at Western Australian Centre for Thrombosis and Haemostasis (WACTH) Murdoch University, Director of Hollywood Hospital Haemophilia Treatment Centre, shared a post on LinkedIn:
“Heavy menstrual bleeding and inherited bleeding disorders are leading causes of iron deficiency—often missed and undertreated.
The new ASH 2026 guidelines recommend screening all women with HMB or inherited bleeding disorders for iron deficiency using a higher ferritin threshold of 50 ng/mL or less—especially before anaemia develops. Early diagnosis and treatment can improve quality of life and health outcomes.
The Perth Blood Institute is launching a women’s blood health initiative in November to boost awareness and best practices for iron deficiency in people affected by heavy menstrual bleeding and bleeding disorders.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke